CPhI South America

Published: 4-Feb-2010

17 - 19 August 2010
La Rural - Hall Ochre, Buenos Aires, Argentina

After two successful editions in Brazil, CPhI South America will move to Argentina from 17 – 19 August 2010. The event will have more than 150 pharmaceutical companies exhibiting from Argentina, Brazil and 20 other countries. New for 2010 is the ICSE Pavilion, a dedicated pavilion for contract services and clinical trials plus an integrated BioPh trail, aimed at those who provide bio-solutions for the pharmaceutical industry. This year again a Match & Meet program will be organised, giving visitors a unique opportunity to expand their network of specially selected suppliers and distributors. For more information, visit www.cphi-sa.com

Trending Articles

  1. Making Pharmaceuticals 23–24 April 2024 | Exhibition | Coventry, UK
  2. Cleanroom Conference UK 22–23 May 2024 | Exhibition | Birmingham, UK
  3. Lounges 23-25 April 2024 | Conference | Messe Karlsruhe, Germany
  4. KOREA CHEM 2023 18-21 April 2023 | Exhibition | Korea
  5. CPhI Worldwide 2011 <b>25 - 27 October 2011</b><br> Messe Frankfurt

You may also like

Manufacturing

CPHI set to return to Milan, Italy in 2024

The world's largest pharmaceutical event is set to return to Milan, Italy in October 2024 and will see figures from all over the industry, spanning the entire supply chain
Manufacturing

Surging demand for Korean pharma in 2023 ahead of CPHI Korea

According to the 2023 CPHI Annual Survey, the Korean pharma industry has seen its "growth potential" increase by 7% as interest grows before the highly anticipated CPHI Korea opening
Manufacturing

CPhI to return to Queen Sirikit National Convention Centre in Bangkok

The event is expecting a record attendance of over 8,000, with a significant number coming from overseas. This represents a near doubling of visitors compared to 2022
Manufacturing

CPHI & PMEC China 2023 see surge from ingredients demand

To help service the expanding demand for pharmaceutical manufacturing, CPHI is co-located alongside PMEC
Regulatory

The big risk for US CDMOs

With many of the largest CDMOs now running at capacity, drug sponsors will need to focus on mitigating risk and building resiliency
Research & Development

Confidence record high in the annual CPHI Pharma Index

Growth and quality scores improved dramatically across all markets, with India the overall biggest winner
Manufacturing

EU supply chain regulation: what will it mean for companies attending CPHI?

Ahead of her session on “Manufacturing Excellence” at CPHI Frankfurt (1–3 November), Elisabeth Stampa, President of Medicines for Europe, along with Adrian van den Hoven, Director General of Medicines for Europe, map out the impact of EU supply chain regulation on pharma companies in an exclusive article for Manufacturing Chemist
Subscribe now